Rosalind Advisors »

Replimune Group shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Replimune Group shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Replimune Group

Tip: Access up to 7 years of quarterly data

All positions including Replimune Group held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Replimune Group by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $183k 511k 0.36
2025-06-30 $516k 232k 2.22

More positions owned by Rosalind Advisors

Delcath Sys Com New (DCTH)
Cytokinetics Com New (CYTK)
Fennec Pharmaceuticals (FENC)
Verastem Com New (VSTM)
Rezolute Com New (RZLT)
Xeris Pharmaceuticals (XERS)
Savara (SVRA)
Mediwound Shs New (MDWD)
Miragen Therapeutics (VRDN)
Cg Oncology (CGON)
Verona Pharma Sponsored Ads (VRNA)
Ideaya Biosciences (IDYA)
Inspiremd (NSPR)
Eyepoint Pharmaceuticals Com New (EYPT)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Rosalind Advisors

Top funds holding Replimune Group

Group One Trading
Rosalind Advisors
Simplex Trading

View all funds holding Replimune Group